Brief: Knight Therapeutics Announces Filing Of New Drug Submission For Crexont® (Carbidopa And Levodopa) Extended-Release Capsules In Canada
18/07/2025 13:27
Amneal Pharmaceuticals Inc AMRX.O: KNIGHT THERAPEUTICS ANNOUNCES FILING OF NEW DRUG SUBMISSION FOR CREXONT® (CARBIDOPA AND LEVODOPA) EXTENDED-RELEASE CAPSULES IN CANADA Source text: ID:nGNX9DCgwV Further company coverage: AMRX.O
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary